is now

Please update your bookmarks and favorites.
You will be taken to the new site in a few seconds.

Real EHR Experience
for Real World Application

Practice Workflow Expertise: The Miraca Life Science Advantage

As a leading pathology service provider, we’ve always had a focus on technology. We’ve worked with numerous EHR systems, and we have a strong history of providing workflow efficiencies and solutions to our clients. By combining our extensive experience and expertise, we’ve created a technology services solution that assists healthcare professionals in advancing workflow efficiency, and guides them towards full EHR integration to get the connectivity and automation they need to become Meaningful Use compliant.

We also offer a dedicated team of response consultants that have extensive experience working with many of the top EHR solutions in the industry. By doing so, we're creating a far more complete support system to meet your needs — you can always reach someone if you have an issue.

Get connected. Contact us at MeaningfulUse@MiracaLS.com or 855.EHR.PATH (347.7284) to learn more about the effective methods that we’re using to implement EHR systems into practices every day.

Complete EHR Integration

The integration and application of an EHR system can be daunting. We work with a variety of EHRs on a daily basis, which is why we strive to find the system that is right for you. Our comprehensive workflow assessment is used to determine your needs, and a system comparison is executed to ensure the proper fit with your practice. We provide the data. You choose the system that best optimizes your practice for success in streamlining efficiencies.

We’re engineering ways to make your workflow experience better — maximizing the efficacy and quality of your care, while driving clinical and practice solutions for today and beyond. Through it all, we provide a level of consultative service that supports your practice beyond EHR integration. We work with you through the multiple phases of Meaningful Use compliance as well as others including PQRS and ICD-10. It's a long-term partnership whose focus is on the success and achievement of your practice.

Break through the perceived barriers of EHR integration. Talk with your customer service representative to discover how we can help you find the right EHR system to strengthen your practice.

Our team has worked with a multitude of EHR solutions, including:

  • ADS — Advanced Data Systems
  • Agastha
  • Allscripts
  • Altos Solutions, Inc.
  • Amazing Charts
  • Aprima Medical Software, Inc.
  • Athena Health
  • Atlas Medical
  • Azalea Health Innovations
  • Cerner
  • Criterions
  • e-MDs
  • eClinicalWorks
  • eDerm Systems
  • edgeMED
  • EHI — Enable Healthcare, Inc.
  • Ellkay
  • Emdeon
  • Encite
  • Endosoft/UTECH Products
  • GE Healthcare — Centricity
  • gMed
  • Greenway Medical Technologies, Inc.
  • HalfPenny Technologies, Inc.
  • Henry Schein (MicroMD)
  • Infinite Software Solutions (MD Reports)
  • LMR — Partners Healthcare
  • Lytec
  • MacPractice
  • Medent
  • MedPlus — Care360/Quest
  • Modernizing Medicine
  • NexTech
  • NextGen HealthCare
  • Office Medicine
  • Olympus America, Inc.
  • OPTUMInsight
  • Orchard Software
  • Partners Community Healthcare, Inc.
  • Pentax of America
  • PerfectCare by NCG Medical
  • Practice Fusion
  • Practice Partners
  • Praxis
  • Provation Medical
  • Source Medical
  • STI Computer
  • Varian
  • Vitera Healthcare
  • WEBeDoctor

Choose Inform Diagnostics for Your Patients


Learn more about Inform Diagnostics' pathology services

Learn More »

When I switched back to Miraca, I did it for pathology reasons. I had no idea they would be able to be so helpful in other respects. Many, many thanks.
— Alan S. Rockoff, MD,
The Rockoff Center for Dermatology, Laser & Plastic Surgery


READ MORE
Learn about Miraca's unmatched quality. We provide our clients with access to the highest quality AP services.

Recent News


January 8, 2018

Miraca Life Sciences Announces Company Name Change to Inform Diagnostics

IRVING, Texas, January 8, 2018 — Miraca Life Sciences announced today that it has changed its name to Inform Diagnostics effective immediately. The company was acquired in November by Avista Capital Partners from previous owner Miraca Holdings. The name Inform Diagnostics and new logo were chosen to highlight the company’s focus on providing pathology and diagnostic capabilities that together help […]

Continue reading


November 20, 2017

Avista Capital Partners Completes Acquisition of Miraca Life Sciences

IRVING, Texas and NEW YORK, Nov. 20, 2017 — Avista Capital Partners (“Avista”), a leading private equity firm, today announced the completion of its acquisition of Miraca Life Sciences (“MLS” or the “Company”) from Miraca Holdings Inc.

Continue reading the press release at the Avista website.

Continue reading


October 16, 2017

Renflexis™ is Latest Addition to Therapeutic Drug Monitoring by Miraca Life Sciences

IRVING, Texas, October 16, 2017 — Miraca Life Sciences, the largest U.S. independent anatomic pathology laboratory, continues to expand in clinical pathology: its InformTx™ therapeutic drug monitoring (TDM) has begun the validation process for Renflexis™ (infliximab-abda), a biosimilar of Remicade® (infliximab). Testing will be commercially available in early November. Since launching the InformTx service in June 2016, Miraca Life Sciences […]

Continue reading


October 3, 2017

Biocept and Miraca Life Sciences Enter Into Marketing Agreement to Expand Target Selector Testing in the United States

MLS to market Biocept’s proprietary liquid biopsy testing platform in key sales territories, with potential to expand the agreement in the future

SAN DIEGO (October 3, 2017) – Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of cancer patients, announces that it has entered […]

Continue reading


September 22, 2017

Avista Capital Partners to Acquire Miraca Life Sciences

IRVING, TX, NEW YORK, NY, and TOKYO, September 22, 2017 – Avista Capital Partners (“Avista”), a leading private equity firm, and Miraca Holdings Inc. (“MHD”) announced today that Avista has signed a definitive agreement to acquire Miraca Life Sciences (“MLS” or “the Company”), a wholly-owned subsidiary of Miraca Holdings Inc. Continue reading press release

Continue reading